ICU Medical Inc
NASDAQ:ICUI
Intrinsic Value
ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. [ Read More ]
The intrinsic value of one ICUI stock under the Base Case scenario is 188.34 USD. Compared to the current market price of 94.53 USD, ICU Medical Inc is Undervalued by 50%.
Valuation Backtest
ICU Medical Inc
Run backtest to discover the historical profit from buying and selling ICUI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
ICU Medical Inc
Current Assets | 1.2B |
Cash & Short-Term Investments | 254.7m |
Receivables | 164.3m |
Other Current Assets | 802.2m |
Non-Current Assets | 3.2B |
Long-Term Investments | 3.1m |
PP&E | 685.5m |
Intangibles | 2.3B |
Other Non-Current Assets | 125.5m |
Current Liabilities | 481.8m |
Accounts Payable | 150m |
Accrued Liabilities | 235.7m |
Other Current Liabilities | 96.1m |
Non-Current Liabilities | 1.8B |
Long-Term Debt | 1.6B |
Other Non-Current Liabilities | 193.5m |
Earnings Waterfall
ICU Medical Inc
Revenue
|
2.3B
USD
|
Cost of Revenue
|
-1.5B
USD
|
Gross Profit
|
739.9m
USD
|
Operating Expenses
|
-675.8m
USD
|
Operating Income
|
64.1m
USD
|
Other Expenses
|
-93.7m
USD
|
Net Income
|
-29.7m
USD
|
Free Cash Flow Analysis
ICU Medical Inc
ICUI Profitability Score
Profitability Due Diligence
ICU Medical Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
ICU Medical Inc's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
ICUI Solvency Score
Solvency Due Diligence
ICU Medical Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Score
ICU Medical Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ICUI Price Targets Summary
ICU Medical Inc
According to Wall Street analysts, the average 1-year price target for ICUI is 138.72 USD with a low forecast of 136.35 USD and a high forecast of 143.85 USD.
Ownership
ICUI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
ICUI Price
ICU Medical Inc
Average Annual Return | -6.1% |
Standard Deviation of Annual Returns | 22.72% |
Max Drawdown | -69% |
Market Capitalization | 2.3B USD |
Shares Outstanding | 24 142 600 |
Percentage of Shares Shorted | 6.48% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 8,500 full-time employees. The firm provides infusion systems, infusion consumables and critical care products used in hospital, alternate site and home care settings. The firm's product portfolio includes IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle free connectors. Its oncology products include ChemoLock and ChemoClave. Its IV consumables include Clave IV Connector Technology, IV Sets, Peripheral IV Catheters and Disinfecting Caps. Its primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. Its IV Solutions products include IV Therapy and Diluents, and Irrigation. Its Infusion System products include Infusion Pump Hardware, IV Mediation Safety Software and Professional Services. The company offers blood pressure monitoring system.
Contact
IPO
Employees
Officers
The intrinsic value of one ICUI stock under the Base Case scenario is 188.34 USD.
Compared to the current market price of 94.53 USD, ICU Medical Inc is Undervalued by 50%.